Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2650-2014Class III

Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R...

Diagnostica Stago, Inc. / initiated 2014-07-18 / Terminated / root cause: labeling and UDI

Diagnostica Stago, Inc. began a recall of Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the... on . FDA classified it as Class III and gives the reason as "Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2650-2014
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Diagnostica Stago, Inc.
Product
Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.
Product code
KFF Assay, Heparin
Reason for recall
Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
Diagnostica Stago sent a "Quality Information" letter/Customer Acknowledgement form to its customers. The letter identified the product, problem, and actions to be taken by the customers. For additional information and further support contact the Diagnostica Stago Hotline at 800-725-0607.
Quantity in commerce
514 kits
Distribution
Distributed USA (nationwide) and the country of Canada.
Product codes and lots
510(k) #K111822, Lot #112366, Part # REF 00311US

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2650-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2650-2014Class IIITerminatedVoluntary: Firm initiated